Ono T - Search Results

1

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.

Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E. Kurashige T, et al. Among authors: ono t. Cancer Res. 2001 Jun 15;61(12):4671-4. Cancer Res. 2001. PMID: 11406534

2

Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.

Kageshita T, Ono T, Hirai S, Yoshii A, Kimura T, Nakakuma H, Horikawa K, Takatsuki K, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Res. 1992 Jun 1;52(11):3201-7. Cancer Res. 1992. PMID: 1350511

3

Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.

Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Res. 1993 Jul 15;53(14):3349-54. Cancer Res. 1993. PMID: 7686817

4

Association between sialyl Lewis(a) expression and tumor progression in melanoma.

Kageshita T, Hirai S, Kimura T, Hanai N, Ohta S, Ono T. Kageshita T, et al. Among authors: ono t. Cancer Res. 1995 Apr 15;55(8):1748-51. Cancer Res. 1995. PMID: 7712483

5

Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.

Wada H, Ono T, Uenaka A, Monden M, Nakayama E. Wada H, et al. Among authors: ono t. Immunology. 1995 Apr;84(4):633-7. Immunology. 1995. PMID: 7790038 Free PMC article.

6

Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.

Uenaka A, Ono T, Akisawa T, Wada H, Yasuda T, Nakayama E. Uenaka A, et al. Among authors: ono t. J Exp Med. 1994 Nov 1;180(5):1599-607. doi: 10.1084/jem.180.5.1599. J Exp Med. 1994. PMID: 7964448 Free PMC article.

7

Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.

Kageshita T, Yoshii A, Kimura T, Kuriya N, Ono T, Tsujisaki M, Imai K, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Res. 1993 Oct 15;53(20):4927-32. Cancer Res. 1993. PMID: 8104688

8

Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.

Kageshita T, Kuriya N, Ono T, Horikoshi T, Takahashi M, Wong GY, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Res. 1993 Jun 15;53(12):2830-3. Cancer Res. 1993. PMID: 8504426

9

IGF2 but not H19 shows loss of imprinting in human glioma.

Uyeno S, Aoki Y, Nata M, Sagisaka K, Kayama T, Yoshimoto T, Ono T. Uyeno S, et al. Among authors: ono t. Cancer Res. 1996 Dec 1;56(23):5356-9. Cancer Res. 1996. PMID: 8968084

10

Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.

Ono T, Uenaka A, Nakayama E. Ono T, et al. Jpn J Cancer Res. 1996 Nov;87(11):1165-70. doi: 10.1111/j.1349-7006.1996.tb03127.x. Jpn J Cancer Res. 1996. PMID: 9045946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,628 results

Search Page

Filters